NASDAQ · AVPT
AvePoint, Inc.
$17.09-$0.26 (-1.5%)
AvePoint, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.45% below the high.
Loading market information…
NYSE · ENFN · USD
Stock price, earnings
Quote as of Apr 17, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Enfusion, Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.81% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Enfusion, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Enfusion, Inc. supplies cloud-based software solutions designed for the investment management sector, operating throughout the United States, Europe, the Middle East, Africa, and the Asia Pacific. Its product suite includes a sophisticated portfolio management system, which establishes an instant and comprehensive investment record. This system incorporates valuation and risk assessment tools, allowing chief investment officers (CIOs) and portfolio managers to analyze aggregated or granular portfolio data. The company also offers an order and execution management system, enabling portfolio managers, traders, compliance teams, and analysts to electronically transmit and manage trade orders across various asset classes. This system simultaneously enforces trading regulations and internal operational guidelines. Additionally, Enfusion provides an accounting and general ledger system that serves as a real-time financial book of record, vital for chief financial officers (CFOs), chief operating officers (COOs), accountants, and operations teams. Furthermore, the Enfusion analytics system empowers CIOs, portfolio managers, traders, and analysts to scrutinize portfolios over different timeframes and automatically generate customized visual reports for both internal and external stakeholders. Complementing these software offerings, Enfusion also delivers technology-powered and managed services. Enfusion Inc. was founded in 2021 and is headquartered in Chicago, Illinois.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 04:23 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q3 2023 | Nov 7, 2023 | $0.04-20.0% vs estimate | $44.36M+1.05% vs estimate |
|---|
| Q2 2023 | Aug 8, 2023 | $0.040.0% vs estimate | $42.72M-4.19% vs estimate |
|---|
THE ANALYST VIEW
8 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$17.09-$0.26 (-1.5%)
AvePoint, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.45% below the high.
$12.15-$0.13 (-1.06%)
Cellebrite DI Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.19% below the high.
$51.93-$6.86 (-11.67%)
Penguin Solutions, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.21% below the high.
$13.96+$0.01 (+0.07%)
WalkMe Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.92% below the high.
$30.00+$0.03 (+0.1%)
Model N, Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.15% below the high.
$3.30$0.00 (0.0%)
E2open Parent Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 28.73% below the high.
$85.90+$0.65 (+0.76%)
MoneyLion Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.58% below the high.
$14.50+$0.39 (+2.76%)
Verb Technology Company, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.29% below the high.
